THE PEPPERS INDEX / PRE-LAUNCHResearch reference library
Get the guide ↗
COMPOUND INDEX

Compound Index.
Understand the research.

Research questions, reported findings, and evidence limits.

Reset

78 matching profiles

Single compounds

5-Amino-1MQ

Examine 5-Amino-1MQ research on NNMT, mouse metabolism, diet combinations and off-target effects, with clear limits on human weight-loss claims.

Read research profile ↗
Single compounds

Adamax

Evaluate Adamax identity and modified-Semax claims, separating related research and name collisions from direct evidence for the exact peptide.

Read research profile ↗
Single compounds

Adipotide

Review Adipotide vascular-targeting research, monkey fat-loss findings, kidney injury and the terminated human trial without inventing its outcomes.

Read research profile ↗
Single compounds

AICAR

Explore AICAR exercise-mimetic research, AMPK-independent effects and the negative RED-CABG acadesine trial, with study-specific evidence limits.

Read research profile ↗
Single compounds

AOD-9604

Examine AOD-9604 human obesity results, animal fat-metabolism studies, GH fragment identity, safety reporting and joint-repair claims.

Read research profile ↗
Blends

AOD-9604 + CJC-1295 + Ipamorelin

Review the triple blend through AOD-9604 animal and human evidence, CJC identity questions and the direct comparisons needed for metabolic claims.

Read research profile ↗
Single compounds

Ara-290

Review ARA-290 and cibinetide human neuropathy studies, corneal nerve measurements, pain outcomes and safety findings with evidence limits.

Read research profile ↗
Single compounds

BPC-157

Review BPC-157 tendon experiments, human knee-pain reports, the two-person safety pilot and FDA findings, with clear limits on clinical claims.

Read research profile ↗
Blends

BPC-157 + TB-500

Evaluate direct rat combination evidence, limited human knee observations, TB-500 identity and finished-formulation questions for the BPC-157 blend.

Read research profile ↗
Single compounds

Cagrilintide

Explore cagrilintide biology, monotherapy weight-loss findings, newer diabetes research, tolerability and the distinction from CagriSema combination results.

Read research profile ↗
Blends

Cagrilintide + Semaglutide

Review CagriSema weight-loss and diabetes trials, component comparisons, the missed REDEFINE 4 target, safety findings and current research status.

Read research profile ↗
Single compounds

Cardiogen

Review Cardiogen rat heart-explant and histone-binding studies, distinguishing tissue growth and proposed mechanisms from clinical cardiac benefit.

Read research profile ↗
Single compounds

Cartalax

Review AED and T-31 research in renal cultures, chondrocytes and human stem cells, separating cartilage markers from proven joint repair.

Read research profile ↗
Single compounds

Cerebrolysin

Compare CARS, CASTA and CERE-LYSE findings, distinguishing early recovery signals, primary endpoints, rehabilitation context and preparation identity.

Read research profile ↗
Single compounds

Chonluten

Examine Chonluten immune-cell signaling and inflammatory findings, including context-dependent responses and the limits of respiratory treatment claims.

Read research profile ↗
Blends

CJC-1295 + GHRP-2

Compare related GHRH and GHRP-2 human experiments, clarifying why hormonal interaction does not validate an unspecified CJC-1295 blend.

Read research profile ↗
Single compounds

CJC-1295 DAC

Explore CJC-1295 DAC human research, GH and IGF-1 findings, formulation differences, FDA safety concerns and the limits of claimed physical benefits.

Read research profile ↗
Stacks

CJC-1295 DAC + Ipamorelin

Separate CJC-1295 DAC and ipamorelin component studies from exact-stack evidence, including a rat muscle study that did not test the pair.

Read research profile ↗

Build your research foundations.

Beginner’s guide

Understanding a COA

Reading a study

STEP 1 study summary